Introduction
The lymphatic vascular system serves key physiological func tions: it maintains fluid homeostasis by absorbing water and macromolecules from the interstitium, enables uptake of dietary lipids and vitamins in the intestine, and serves as a trafficking route for immune cells. The lymphatic vasculature consists of a highly branched network of capillaries and ducts that is present in most organs with the exception of the central nervous system and avascular tissues, such as cartilage. Unlike the blood vas culature, the lymphatic vasculature is blind ending (Fig. 1 A) : its small capillaries funnel first into precollecting and larger col lecting vessels and then into the thoracic duct or the right lym phatic trunk, which drains lymph into the subclavian veins.
Malfunctioning of the lymphatic vasculature results in lymphedema formation and compromises immune function. In the past decade, tremendous progress has been achieved in understanding the mechanisms regulating the morphogenesis of lymphatic vasculature, mainly accomplished by genetically modified mouse models and discovery of mutations respon sible for human lymphedema syndromes. In addition, models, such as zebrafish and frog tadpoles, are emerging as powerful tools for studying lymphatic vascular development. In this re view, we will summarize the main mechanisms underlying the development of lymphatic vasculature and present an overview of several human diseases that are associated with lymphatic vessel abnormalities.
Mechanisms of lymph transport
The structure of the different lymphatic vascular compartments, such as capillaries, precollecting, and collecting lymphatic ves sels, reflects its dual role in fluid absorption and lymph trans port. We will briefly present the main aspects of lymph transport, which have been documented in more detail in recent reviews (Dejana et al., 2009; Zawieja, 2009 ).
Fluid and cell uptake by lymphatic capillaries.
Lymphatic capillary endothelium has a unique junctional orga nization (Baluk et al., 2007; Dejana et al., 2009) . Oak leaf-shaped endothelial cells are connected by discontinuous buttonlike junctions. Free overlapping cell edges anchored on each side by these junctions form "flap valves" (Fig. 1 , B and C) through which fluid flows unidirectionally along pressure gradients from the interstitium into the capillary lumen. Actively sprouting lymphatic capillaries have continuous cell-cell junctions, sug gesting buttonlike junctions as characteristics of quiescent and functional lymphatic capillary endothelium (Baluk et al., 2007) . Lymphatic capillaries lack mural cells and connect to the ECM via anchoring filaments (Leak and Burke, 1968) , which prevent the collapse of capillaries upon the increase of interstitial pres sure (Fig. 1 B) .
The lymphatic vasculature constitutes a highly specialized part of the vascular system that is essential for the mainte nance of interstitial fluid balance, uptake of dietary fat, and immune response. Recently, there has been an in creased awareness of the importance of lymphatic vessels in many common pathological conditions, such as tumor cell dissemination and chronic inflammation. Studies of embryonic development and genetically engineered animal models coupled with the discovery of mutations under lying human lymphedema syndromes have contributed to our understanding of mechanisms regulating normal and pathological lymphatic morphogenesis. It is now crucial to use this knowledge for the development of novel therapies for human diseases.
Shear stress generated by transcapillary fluid flow regu lates the expression of junctional proteins, upregulates leuko cyte adhesion molecules ICAM1 and Eselectin, and promotes secretion of chemokine CCL21, mediating dendritic cell migra tion (Miteva et al., 2010) . Thus, mechanical stimulation may be important for immune surveillance function of lymphatic vasculature. Dendritic cells first squeeze through pores that punctuate the sparse basement membrane of lymphatic capillar ies and, subsequently, reach the lumen through interendothelial flap valves (Fig. 1 B ; Pflicke and Sixt, 2009) . They are then transported toward the draining lymph nodes where they induce immune responses. Interstitial components penetrate lymphatic capillaries via openings between LECs. The specialized structure of such openings prevents the return of lymph back to the interstitium. Anchoring filaments attach LECs to the ECM and prevent vessel collapse under conditions of increased interstitial pressure (black arrow). (C) Junctional organization of LECs in lymphatic capillaries and collecting vessels. Both "buttons" and "zippers" share a repertoire of adherens and tight junction-associated proteins (e.g., VE-cadherin, zonula occludens-1, occludin, and claudin-5). The main difference between them resides in their organization (Baluk et al., 2007) . (D) Mechanism of lymph propulsion in collecting vessels. Coordinated opening and closure of lymphatic valves is important for efficient lymph transport. SMCs covering each lymphangion possess intrinsic contractile activity. EC, endothelial cell.
lymph hearts located at the junctions of the lymphatic and venous systems control lymph flow (Kampmeier, 1969) .
Lymphatic vascular morphogenesis
Lymphatic vascular development requires transdifferentiation of venous endothelial cells toward the lymphatic endothelial phenotype, separation of blood and lymphatic vasculature, sprout ing of lymphatic vessels, and lymphatic vascular maturation (Fig. 2 A) . Over 20 genes orchestrate these processes in mice (Table I) , and recently, lymphangiogenesis has also been exam ined in lower vertebrates, such as fish and frogs.
Establishment of LEC identity and lymphatic sprouting. Lymphatic vessels stem from preexisting blood vessels. Elegant lineage tracing by Srinivasan et al. (2007) dem onstrated the venous origin of the mammalian lymphatic vascu lature as previously proposed (Sabin, 1902; Kaipainen et al., 1995) . The venous origin of LECs has been confirmed in Xenopus laevis and zebrafish as shown by realtime imaging in the latter and, therefore, appears to be evolutionary conserved (Ny et al., 2005; Yaniv et al., 2006; Hogan et al., 2009a) .
Lymphatic valves contain two semilunar leaflets, which are covered on both sides by a specialized endothelium an chored to the ECM core (Lauweryns and Boussauw, 1973) . High lymph pressure upstream of a valve opens the valve and enables lymph flow, whereas reverse flow pushes the leaflets against each other and closes the valve (Fig. 1 D) . Therefore, opening and closing of the valve depend on periodic changes in fluid pressure within collecting vessels. The number of valves per vessel segment varies depending on tissue type, being gen erally highest in organs with high hydrostatic pressure, e.g., legs in humans (Földi et al., 2006) .
Cyclical compression and expansion of lymphatic ves sels by surrounding tissues and intrinsic pump forces gener ated by the spontaneous phasic contraction of SMCs regulate lymph propulsion (Zawieja, 2009) . The origin of lymphatic SMCs is unknown, but they contain both smooth and striated muscle contractile proteins and, thus, differ from arteriole SMCs (Muthuchamy et al., 2003) . Nitric oxide, hormones, and prostanoids control SMC contractions (Zawieja, 2009) . In am phibians and reptiles, specialized pulsatile muscular organs or Table I ). Interaction of podoplanin on LECs and CLEC-2 on platelets triggers the Syk-, Slp76-, and PLC-2-dependent signaling cascade leading to platelet aggregation. O-glycosylation by T-synthase is important for podoplanin function. (Karkkainen et al., 2001; Mäkinen et al., 2001; Kärpänen et al., 2006b) . In zebrafish, the secreted protein Ccbe1 controls lymphatic sprouting from veins, and its function is conserved, as CCBE1 mu tations cause human syndrome presenting with lymphatic dysplasia (Alders et al., 2009; Hogan et al., 2009a ; see Heredity lymphedema syndromes). The venous origin of LECs and conserved function of VEGFC, VEGFR3, and CCBE1 (Karkkainen et al., 2000 (Karkkainen et al., , 2003 Ny et al., 2005; Küchler et al., 2006; Yaniv et al., 2006; Alders et al., 2009; Hogan et al., 2009a,b) clearly underpin the common origin of the vertebrate lymphatic vasculature. Nevertheless, within this common scheme, there seem to be differences between mam malian and zebrafish LEC behavior: in mice, lymphatic sprouting occurs after veins have formed, whereas zebrafish venous sprouts and lymphatic precursors emerge from the cardinal vein simul taneously . Half of those venous sprouts connect with intersegmental vessels to form veins, whereas other sprouts disconnect from the vein and migrate toward the horizon tal myoseptum region, constituting a pool of future LECs. These cells, called parachordal lymphangioblasts, migrate along arteries either dorsally to form intersegmental lymphatic vessels or ven trally to form the thoracic duct Geudens et al., 2010) . At 5 d after fertilization, a functional lymphatic sys tem has been established in the zebrafish trunk capable of taking up substances from the interstitium and of transporting lymph into the venous system (Küchler et al., 2006; Yaniv et al., 2006) . Future studies will have to show whether the requirement for arteries in guiding LEC migration is a zebrafishspecific feature or whether this represents a general scheme among vertebrates: the anatomical proximity of mammalian arteries and lymphatic vessels has often been noted but commonly attributed to high arterial pressure and a need of absorbing extravasated water and proteins near arteries. Using zebrafish, a role for Notch/Dll4 signaling has been demon strated in guiding LECs along arteries , and there might be earlier roles for Notch at the level of venous sprout ing (Liao et al., 2010) . Interestingly, loss of the arterial regulator synectin also compromises the development of zebrafish lymphat ics .
Hematopoietic cells and lymphatic vascular
development. In mammals, lymphatic and blood vascula tures are connected only in a few defined locations where lymph is returned back to blood circulation. Platelets are important for keeping both vascular systems apart (Table I) : platelet deple tion or defective platelet aggregation leads to abnormal lympho venous connections and bloodfilled lymphatic vessels (Ichise et al., 2009; Bertozzi et al., 2010; Carramolino et al., 2010; Suzuki Inoue et al., 2010; Uhrin et al., 2010) . According to the current model, platelets aggregate at sites of communication between the cardinal vein and lymph sacs and "seal off" lymphatic vessels from the vein (Fig. 2, A and D) . Platelet aggregation is initiated by binding of the Oglycosylated mucoprotein podoplanin expressed on LECs to the Clec2 receptor on platelets (Bertozzi et al., 2010; Uhrin et al., 2010) . Clec2 further induces intracellular signaling In mice, LECs are first specified in the anterior cardinal vein around embryonic day 9.5 (E9.5) when a subset of venous endo thelial cells expresses the transcription factor Prox1 and the lym phatic vessel hyaluronan receptor1 (LYVE1) in a polar manner (Fig. 2 B) . Prox1 / mice do not develop any lymphatic structures because of failed budding and sprouting of LECs . The transcription factor Sox18 induces Prox1 ex pression, and Sox18 / mice develop edema caused by blockage of LEC development in the vein in certain genetic backgrounds (François et al., 2008) . In vitro studies demonstrate SOX18 bind ing to the Prox1 promoter and show that PROX1 can confer lym phatic identity to blood endothelial cells (BECs; Hong et al., 2002; Petrova et al., 2002; François et al., 2008) . Thus, Sox18 and Prox1 constitute an essential signaling axis for LEC specification. The nuclear receptor CoupTFII (Lin et al., 2010; Srinivasan et al., 2010) has an earlier developmental role as a venous identity factor, but it also directly interacts with Prox1 (Lee et al., 2009; Yamazaki et al., 2009 ) and regulates the expression of LECspecific genes, such as neuropilin2 (Nrp2; Lin et al., 2010) .
Prox1/LYVE1-positive cells bud and migrate dorsolater ally from the central veins. They subsequently form the first bona fide lymphatic structures (jugular lymph sacs) in regions where lymphangiogenic growth factor Vegfc is provided by the lateral mesoderm (Fig. 2 A; Karkkainen et al., 2003) . This process occurs at several positions along the anterior-posterior axis of the early embryo and results in the formation of jugular, medial, and axial lymph sacs, which further give rise to a primary capillary plexus (Sabin, 1902) . Vegfc is critical in the process: Vegfc / mice lack all lymphatic vasculature, and even Vegfc +/ displays lymphatic hypoplasia (Karkkainen et al., 2003) . The sprouting response of LECs to VEGFC is mediated by the receptor tyro sine kinase VEGFR3 and its nonsignaling transmembrane co receptor Nrp2 (Fig. 2 C) . Nrp2 is highly expressed in lymphatic capillaries and becomes internalized together with VEGFR3 upon stimulation of LECs with VEGFC and VEGFD (Kärpänen et al., 2006a) . Intriguingly, Nrp2 is important for capillary sprout ing but dispensable for the formation of lymph sacs (Yuan et al., 2002; Xu et al., 2010) . Vegfr3 is initially expressed also in BECs but becomes mostly restricted to LECs after E10.5. Vegfr3 sig naling depends on interaction with claudinlike protein Clp24 and receptor internalization, a process requiring ephrinB2 Wang et al., 2010) . Interestingly, the combined dele tion of Vegfr3 ligands Vegfc and Vegfd in mice does not pheno copy the inactivation of Vegfr3, pointing to a ligandindependent Vegfr3 function (Haiko et al., 2008) . Budding of LECs from veins requires Vegfr3 kinase activity, whereas deletion of the Vegfr3 ligandbinding domain does not alter lymph sac formation (Fig. 2 , A-C; Zhang et al., 2010) . Proteolytically processed VEGFC also interacts with VEGFR2, which is expressed by lymphatic endothelium. However, activation of Vegfr2 alone promotes lymphatic vessel enlargement but not sprouting (Wirzenius et al., 2007) . VEGFC induces formation of VEGFR2/ VEGFR3 heterodimers at angiogenic tip cells, suggesting that heterodimerization of VEGFR3 with VEGFR2 may contribute to lymphangiogenic sprouting (Nilsson et al., 2010) . Endothelial specific loss of Rho GTPase Rac1 leads to an abnormally close association of lymph sacs and cardinal veins, suggesting that it stabilization, and they also control lymphatic vascular develop ment. Mice hypomorphic for Tie1 exhibit LEC hyperplasia and abnormal remodeling of lymph sacs, whereas mice deficient in one of the Tie2 ligands, angiopoietin2, show defective lymphatic vascular remodeling and lack valves (Gale et al., 2002; Dellinger et al., 2008; D'Amico et al., 2010) . Tie2 activation induces phosphoinositide (PI) 3kinase and Akt signaling in vitro, and consistent with these observations, mutations in several PI3kinase pathway components or loss of Akt1 leads to lymphaticremodeling defects (Gupta et al., 2007; MoutaBellum et al., 2009; Zhou et al., 2010) . Zebrafish tie2 / undergoes normal lymphangio genesis. However, redundancy with Tie1 needs to be examined (Gjini et al., 2011) .
Pathological lymphatic vascular morphogenesis
Given the importance of lymphatic vessels for normal body functions, it is not surprising that defects of the lymphatic vascu lature are implicated in a variety of human pathologies. Roles of lymphatic vessels in tumor metastasis and inflammation have been recently covered in several excellent reviews (Sleeman et al., 2009; Tammela and Alitalo, 2010) . Here, we will concen trate on the defects of vascular morphogenesis in human lymph edema syndromes and some rare but debilitating diseases in which lymphatic vasculature is suggested to play a central role.
Hereditary lymphedema syndromes. Lymphatic vessel dysfunction results in progressive accumulation of protein rich interstitial fluid and formation of nonpitting localized tis sue swelling or lymphedema (Fig. 3) . It is a chronic debilitating condition associated with increased local susceptibility to infec tions and certain cancers, such as angiosarcoma. Lymphedema can be inherited (primary lymphedema) but is more com monly caused by damage incurred by collecting lymphatic vessels or lymph nodes during cancer surgery or radiation ther apy (secondary lymphedema). Pathologies of secondary lymph edema have recently been reviewed (Rockson, 2001 (Rockson, , 2008 Tammela and Alitalo, 2010) .
Hereditary lymphedema is a rare genetic disorder, which can develop in utero, neonatally, or more frequently, years or de cades after birth (Fig. 3 and Table II ). Missense mutations within the VEGFR3 tyrosine kinase domain cause Milroy disease, which is characterized by underdeveloped and dysfunctioning cutaneous lymphatic vessels (Karkkainen et al., 2000; Mellor et al., 2010) . Recently, mutations in the recessive CCBE1 gene, shown to con trol lymphatic sprouting in zebrafish (Hogan et al., 2009a) , have been identified in a subset of Hennekam syndrome patients, who develop limb lymphedema, dilated intestinal lymphatic vessels, mental retardation, and facial anomalies (Alders et al., 2009) . Intestinal lymphatic capillaries are also reduced in number and abnormally patterned, suggesting that defective lymphatic capil lary function is a cause of the syndrome (Alders et al., 2009) .
Lossoffunction mutations in FOXC2 cause lymphedemadistichiasis syndrome (LD), which is characterized by late onset lymphedema and a double row of eyelashes (distichiasis; Fang et al., 2000) . Gainoffunction mutations in FOXC2 occur in patients with lymphedema, but the association of these muta tions with distichiasis awaits further investigation (van Steensel cascades mediated by spleen tyrosine kinase (Syk), Slp76, and PLC2, which then lead to formation of the blood clot that seals off the vein from the lymph sac (Ichise et al., 2009; Bertozzi et al., 2010; SuzukiInoue et al., 2010) .
In addition to platelets, myeloid cells regulate lymphatic vas cular morphogenesis. Macrophagedeficient PU.1 / and Csfr1 / mice exhibit hyperplastic dermal lymphatic capillaries, suggesting that macrophages restrict proliferation of LECs (Gordon et al., 2010) . Conversely, abnormal accumulation of myeloid cells, pro ducing high levels of cytokines and VEGFD, induces the forma tion of dermal lymphaticovenous shunts in Syk / mice (Böhmer et al., 2010) . Similar mechanisms are likely at play in Angptl4 / mice, in which excessive macrophage activation by chylomicrons may be responsible for fusion of intestinal blood and lymphatic vessels (Bäckhed et al., 2007; Lichtenstein et al., 2010) .
Lymphatic vascular remodeling and maturation.
Starting from E15.5, the lymphatic vasculature is reorganized into lymphatic capillaries, precollectors, and collecting lymphatic ves sels (Fig. 2 A) . In mice, transient upregulation of the forkhead transcription factor Foxc2 is the first sign of formation of collecting lymphatic vessels (Norrmén et al., 2009) . Lymphatic valves con tinue to express high levels of Foxc2 and Prox1 throughout devel opment and in adults. LECs in any given lymphangion decrease the expression of Prox1, Vegfr3, LYVE1, and Ccl21, secrete base ment membrane components, and acquire SMC coverage (Mäkinen et al., 2005; Norrmén et al., 2009 ). In the absence of Foxc2, transi tion from capillary to collecting lymphatic vessel phenotype and formation of lymphatic valves are arrested (Petrova et al., 2004; Norrmén et al., 2009 ). FOXC2bound enhancers in LECs are sur rounded by nuclear factor of activated T cells (NFAT) binding sites, and pharmacological inhibition of NFAT activation results in lymphatic patterning defects reminiscent of Foxc2 / phenotypes (Norrmén et al., 2009 ). This suggests that Foxc2 and NFAT path ways cooperate in establishing collecting lymphatic vessels.
Ephrin-Eph signaling is essential for embryonic angio genesis, and targeted inactivation in mice of ephrinB2 or its re ceptor EphB4 leads to aberrant embryonic blood vessel formation (Adams and Eichmann, 2010) . Reverse signaling via PDZ inter action sites of ephrinB2 is also required for the maturation of collecting lymphatic vessels (Mäkinen et al., 2005) . In mice, the presence of a mutation in this PDZ interaction site of ephrinB2 prevents the formation of valves and leads to persistent LYVE1 expression in presumptive collecting vessels. These mutant mice also display defective sprouting of lymphatic capillaries, which acquire ectopic SMC coverage (Mäkinen et al., 2005) .
Integrin 9 and its ligand fibronectin (FN) containing the EIIIA domain (FNEIIIA) control later steps of lymphatic valve formation (Bazigou et al., 2009 ). The integrin 9-1 complex binds to FNEIIIA, tenascin, and osteopontin in vitro and regu lates the organization of FNEIIIA microfibrils. Loss of integrin 9 prevents the elongation of valve leaflets, resulting in the forma tion of ringlike constrictions, which are unable to prevent lymph backflow (Bazigou et al., 2009) . Fn-EIIIA / mice have a similar phenotype, demonstrating that FNEIIIA is a physiologically relevant integrin 9 ligand (Bazigou et al., 2009) .
The Tie1 and Tie2 endothelial receptor tyrosine kinases are essential for blood vascular remodeling, maturation, and distant sites, where they may block lymphatic function, causing accumulation of lymph in the chest and abdominal cavity and lymphedema. The cystic destruction of the lung parenchyma over time impairs lung function, which is ultimately only rescu able through lung transplantation (Seyama et al., 2010) .
The kinase mammalian target of rapamycin (mTOR) plays a central role in integrating growth factor-activated signaling. Its abnormal activation is a likely cause of LAM, as patients with germline mutations of mTOR repressors tuberosis sclero sis complex1 and 2 (TSC1 and TSC2) genes develop the dis ease. Somatic biallelic loss of TSC2 occurs in sporadic LAM cases (Carsillo et al., 2000; Sato et al., 2002) . In line with these findings, encouraging results were observed in patients treated with mTOR inhibitors (Glasgow et al., 2010) . Given the close association of LAM cells with lymphatic vessels and the lym phatic pattern of dissemination, combining the blockage of mTOR with antilymphangiogenic therapy seems to be a reason able further step in developing better treatment for this disease.
Gorham disease (GD). GD is a rare disease of unknown etiology characterized by bone resorption and local vascular pro liferation. The disease is frequently complicated by systemic dysfunction of lymphatic vessels, such as chylothorax and chy lous ascites (Radhakrishnan and Rockson, 2008) . Endothelial cells in the lesions are likely of LEC origin, as they express LEC markers LYVE1 and podoplanin, and VEGFR3 is increased in 50% of vessels (Hagendoorn et al., 2006) . Nonendothelial cells from GD lesions resemble immature osteoclasts; they se crete cytokines and angiogenic factors, are highly invasive, and may, thus, contribute to disease progression (Colucci et al., 2006) . Moreover, GD osteoclast precursors show increased sen sitivity to humoral factors, promoting osteoclast formation and bone resorption (Hirayama et al., 2001) . Overall, the clinical pic ture points to an intriguing link between LEC proliferation and activation of osteoclastmediated bone resorption; however, at present, no candidate genes for GD have been identified.
Kaposi sarcoma (KS): a case of mixed identity.
KS is a tumor caused by human herpes virus 8 (HHV8 or et al., 2009) . Lymphatic vessel density is normal or increased in LD patients; however, lymphatic transport is inefficient because of lymph reflux, likely caused by incompetent lymphatic valves. LD patients also have venous reflux, suggesting a common mechanism for the morphogenesis of venous and lymphatic valves (Brice et al., 2002; Mellor et al., 2007) Dominantnegative mutations in SOX18 occur in hypo trichosis-lymphedema-telangiectasia syndrome (HLT) character ized by sparse hair, swelling of legs, and dilation of small blood vessels. Based on phenotypic similarities with mice producing a dominantnegative form of Sox18, HLT patients likely have lym phatic capillary hypoplasia (Irrthum et al., 2003; François et al., 2008) . Novel causes of hereditary lymphedema include muta tions in gap junction protein GJC2 and protein tyrosine phospha tase PTPN14 (Au et al., 2010; Ferrell et al., 2010) . GJC2 is highly expressed by oligodendrocytes, and recessive lossoffunction mutations in GJC2 cause hereditary Pelizaeus-Merzbacherlike disease, which is characterized by central nervous system de myelination. Given the dominant character of GJC2 mutations in lymphedema, mutant proteins might exert a dominantnegative effect either on remaining wildtype GJC2 molecules or other connexins. A subset of Ptpn14deficient mice has hyperplas tic lymphatic vasculature, and a role for PTPN14 in restricting Vegfr3 activation has been proposed (Au et al., 2010) .
Lymphangioleiomyomatosis (LAM). LAM is a rare lung disease affecting women of childbearing age characterized by the proliferation of smooth muscle-like cells and lymphatic vessels as well as the formation of pulmonary cysts. LAM can also occur in the axial lymphatics and is associated with a benign kidney tumor angiomyolipoma (Seyama et al., 2010) . The origin of the SMCs in LAM lesions is unknown, but they respond to estrogen and express multiple chemokine receptors and lym phangiogenic growth factors VEGFC and VEGFD, which may explain the highly metastatic behavior of LAM cells and their close association with lymphatic vessels (PachecoRodriguez et al., 2009; Yu et al., 2009) . LAM is a benign neoplasm. However, LAM cells frequently disseminate through lymphatic vessels to Figure 3 . Causes of human hereditary lymphedemas. Lymph transport can be impaired because of a hypoplastic initial lymphatic capillary network, because of abnormal coverage of lymphatic capillaries with basement membrane components and SMCs or because of a lack of or malfunctioning lymphatic valves. Defective lymphatic drainage leads to tissue fibrosis and fat deposition caused by the abnormal local chronic inflammatory response. Genes that are mutated in human hereditary lymphedema are indicated in blue next to the processes to which they are thought to be causally related. Mechanisms of the action of GJC2, PTPN14, and IKBKG are not fully understood.
production of proangiogenic and inflammatory cytokines, and un restricted replicative potential (Mesri et al., 2010) . Notably, some of these molecules control endothelial cell differentiation in vitro: four KS microRNAs target the transcription factor MAF and con tribute to reprogramming of the LEC to BEC phenotype, whereas kaposinB stabilizes PROX1 mRNA, which has a key role in lymphatic endothelial identity (Hansen et al., 2010; Yoo et al., 2010) . Overall, these data provide an intriguing example of virus mediated change of the endothelial cell differentiation program.
Open questions and outlook
Impressive progress has been achieved in the past decade in the field of lymphatic vascular biology, but many questions remain KSassociated herpes virus [KSHV] ). The lesions are composed of spindleshaped tumor cells, leaky and highly proliferative vessels, extravasated red blood cells, and inflammatory infiltrate (Mesri et al., 2010) . KS cells express markers of both blood (CD34 and CXCR4) and LEC lineages (VEGFR3, LYVE1, and podoplanin). Interestingly, KSHV infection of BECs shifts the transcriptional profile toward a LEC phenotype, whereas KSHV infection of LECs induces transcriptional reprogramming toward a more BEClike phenotype (Hong et al., 2004; Wang et al., 2004) .
The major latency viral transcripts expressed in KS cells include the latencyassociated nuclear antigen, viral cyclin, vFLIP, viralencoded microRNAs, and kaposinA and B. These transcripts are important for KHSVinduced cell proliferation, 
